A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosisSANTORO, A; SIMONELLI, M; LAMAR, M et al.British journal of cancer. 2013, Vol 108, Num 1, pp 21-24, issn 0007-0920, 4 p.Article

Irinotecan and raltitrexed: an active combination in advanced colorectal cancerCARNAGHI, C; RIMASSA, L; GARASSINO, I et al.Annals of oncology. 2002, Vol 13, Num 9, pp 1424-1429, issn 0923-7534, 6 p.Article

Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanomaBAJETTA, E; DEL VECCHIO, M; MORTARINI, R et al.Clinical cancer research. 1998, Vol 4, Num 1, pp 75-85, issn 1078-0432Article

5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumorsBAJETTA, E; RIMASSA, L; CARNAGHI, C et al.Cancer. 1998, Vol 83, Num 2, pp 372-378, issn 0008-543XArticle

Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFTDI BARTOLOMEO, M; PIETRANTONIO, F; PASSALACQUA, R et al.Targeted oncology. 2014, Vol 9, Num 2, pp 155-162, issn 1776-2596, 8 p.Article

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysisPRESSIANI, T; BONI, C; LATINI, L et al.Annals of oncology. 2013, Vol 24, Num 2, pp 406-411, issn 0923-7534, 6 p.Article

Serum markers of bone metastases in postmenopausal breast cancer patients treated with formestaneMARTINETTI, A; BAJETTA, E; SEREGNI, E et al.Tumor biology. 1997, Vol 18, Num 4, pp 197-205, issn 1010-4283Article

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinomaSANTORO, A; PRESSIANI, T; COLOMBI, S et al.British journal of cancer. 2010, Vol 103, Num 6, pp 837-844, issn 0007-0920, 8 p.Article

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patientsCAPPUZZO, F; VARELLA-GARCIA, M; HOLMES, A. J et al.British journal of cancer. 2008, Vol 99, Num 1, pp 83-89, issn 0007-0920, 7 p.Article

A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancerSANTORO, A; COMANDONE, A; PRESSIANI, T et al.Annals of oncology. 2008, Vol 19, Num 11, pp 1888-1893, issn 0923-7534, 6 p.Article

Clinical significance of neuroendocrine phenotype in non-small-cell lung cancerCARNAGHI, C; RIMASSA, L; GARASSINO, I et al.Annals of oncology. 2001, Vol 12, pp 119-123, issn 0923-7534, SUP2Conference Paper